// App-Quantinova.ai

: Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF: analysis from the Swedish IPF registry

Researchers

Presenter

  • Jing Gao

Principal Investigators

  • Dimitrios Kalafatis

  • Lisa Carlson

  • Chuan-Xing Li

  • Ida Pesonen

  • Magnus Sköld

Medical Centers

  • Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  • Division of Respiratory Medicine, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden

  • epartment of Respiratory Medicine and Allergy, Karolinska University Hospital; Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

  • Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  • epartment of Respiratory Medicine and Allergy, Karolinska University Hospital; Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A